Phosphodiesterase 5 inhibitors in vascular systemic disorders

被引：4
作者：
Allanore, Yannick [1 ]
机构：
[1] Univ Paris 05, INSERM U1016, Serv Rhumatol, Hop Cochin, F-75014 Paris, France
来源：
JOINT BONE SPINE | 2012年 / 79卷 / 04期
关键词：
Phosphodiesterase; Nitric oxide; Pulmonary hypertension; Raynaud's phenomenon; Sildenafil; Tadalafil; PULMONARY ARTERIAL-HYPERTENSION; RAYNAUDS-PHENOMENON RESISTANT; DOUBLE-BLIND; SILDENAFIL; THERAPY; TADALAFIL; SCLEROSIS; EFFICACY;
D O I：
10.1016/j.jbspin.2011.12.009
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：338 / 340
页数：3
相关论文
共 50 条
[31]   Phosphodiesterase 5 inhibitors (PDE5i) for the treatment of Raynaud's phenomenon [J].
Maltez, Nancy ;
Maxwell, Lara J. ;
Rirash, Fadumo ;
Ghogomu, Elizabeth Tanjong ;
Harding, Sarah E. ;
Tingey, Paul C. ;
Wells, George A. ;
Tugwell, Peter ;
Pope, Janet .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2023, (11)
[32]   The use of phosphodiesterase 5 inhibitors with concomitant medications [J].
Corona, G. ;
Razzoli, E. ;
Forti, G. ;
Maggi, M. .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2008, 31 (09) :799-808
[33]   The use of phosphodiesterase 5 inhibitors with concomitant medications [J].
G. Corona ;
E. Razzoli ;
G. Forti ;
M. Maggi .
Journal of Endocrinological Investigation, 2008, 31 :799-808
[34]   Cardiovascular Effects of Phosphodiesterase Type 5 Inhibitors [J].
Vlachopoulos, Charalambos ;
Ioakeimidis, Nikolaos ;
Rokkas, Konstantinos ;
Stefanadis, Christodoulos .
JOURNAL OF SEXUAL MEDICINE, 2009, 6 (03) :658-674
[35]   Is there a place for treatment with type 5 phosphodiesterase inhibitors in heart failure patients? [J].
Josiak, Krystian ;
Inorowicz, Ewa ;
Kremis, Elzbieta ;
Jankowska, Ewa Anita ;
Banasiak, Waldemar ;
Ponikowski, Piotr .
KARDIOLOGIA POLSKA, 2011, 69 (09) :952-957
[36]   Phosphodiesterase-5 inhibitors for the treatment of Raynaud's: a novel indication [J].
De LaVega, Alfonso J. ;
Derk, Chris T. .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2009, 18 (01) :23-29
[37]   Oral phosphodiesterase type 5 inhibitors and male reproductive potential: an overview [J].
Mostafa, Taymour ;
Alghobary, Moheiddin ;
Hanafy, Noha S. ;
Abosief, Ahmed .
SEXUAL MEDICINE REVIEWS, 2023, 11 (03) :240-252
[38]   Effectiveness and Safety of Phosphodiesterase 5 Inhibitors in Patients with Cardiovascular Disease and Hypertension [J].
Chrysant, Steven G. .
CURRENT HYPERTENSION REPORTS, 2013, 15 (05) :475-483
[39]   The Controversial Role of Phosphodiesterase Type 5 Inhibitors in the Treatment of Premature Ejaculation [J].
Jannini, Emmanuele A. ;
McMahon, Chris ;
Chen, Juza ;
Aversa, Antonio ;
Perelman, Michael .
JOURNAL OF SEXUAL MEDICINE, 2011, 8 (08) :2135-2143
[40]   Evaluating preference trials of oral phosphodiesterase 5 inhibitors for erectile dysfunction [J].
Mulhall, JP ;
Montorsi, F .
EUROPEAN UROLOGY, 2006, 49 (01) :30-37
12345